While clinical laboratory Quest Diagnostics (DGX) had a rough outing last week, speculators seeking a discount may want to ...

Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts. On June ...

This was the stock's second consecutive day of losses.

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Quest Diagnostics is expected to unveil its second-quarter results later this month, and analysts expect a single-digit ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. | The Lumipulse G blood test measures the ratio between ...

Looking back on testing & diagnostics services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, ...

Quest Diagnostics (1% YTD Return, $14 billion market cap): While Quest - one of the largest U.S. diagnostics chains - has been impacted by the pandemic and associated shutdowns, as diagnostic ...

Quest Diagnostics CIO Lidia Fonseca is a Forbes CIO Innovation Award winner on the strength of the role she has played in developing Quanum, a suite of technology and data analytics solutions ...

Quest Diagnostics on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's disease protein that can appear years before dementia ...

Quest Diagnostics Inc. closed 5.99% below its 52-week high of $182.38, which the company achieved on June 16th.